|
|
||||||||
1 Molecular Sciences Department, Wellcome Research Laboratories, Langley Court, Beckenham, Kent BR3 3BS U.K.
and2 Max-Planck-Institut fuer Molekulare Genetik, Abt. Schuster, Berlin, Germany
The C-terminal region of human immunodeficiency virus (HIV) reverse transcriptase (RT) contains the domain responsible for RNase H activity. To determine the importance of this RNase H domain, specific changes in the C-terminal region of a recombinant RT expressed in Escherichia coli were introduced by amino acid substitutions and specific deletions. The enzyme activities of purified wild-type and mutant RT/RNase H proteins, standardized for protein content, were compared by filter assays and thermal inactivation kinetics. A point mutation of His 539
Asn produced an enzyme with a marked thermolabile RNase H function (nine-fold increase in inactivation), whereas RT function was only marginally more labile than that of the wild-type (two-fold). A second mutation, His 539
Asp, impaired both enzyme activities to a similar degree (four- to five-fold). A C-terminal deletion of 19 amino acids (aa) (aa 540 to 558) and a C-terminal truncation of 21 aa (aa 540 to 560) reduced RT as well as RNase H activity. A 130 aa deletion enzyme exhibited no RNase H activity and insufficient RT activity to allow inactivation studies. Two mutants, the 19 aa deletion and His
Asn, were introduced into proviral HIV-1 DNA clones to determine whether changes in enzyme activity, particularly RNase H activity, affected virus infectivity. Both mutants were non-infectious, indicating that the C-terminal 19 to 21 amino acids and His 539 of the RT/RNase H protein are essential for HIV replication. These results are consistent with the assumption that RNase H is essential for the infectivity of HIV-1.
Received 9 July 1990;
accepted 21 September 1990.
This article has been cited by other articles:
![]() |
M. Ntemgwa, M. A. Wainberg, M. Oliveira, D. Moisi, R. Lalonde, V. Micheli, and B. G. Brenner Variations in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Are Associated with Divergent Phenotypic Resistance to Zidovudine Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3861 - 3869. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Purohit, M. Balakrishnan, B. Kim, and R. A. Bambara Evidence That HIV-1 Reverse Transcriptase Employs the DNA 3' End-directed Primary/Secondary RNase H Cleavage Mechanism during Synthesis and Strand Transfer J. Biol. Chem., December 9, 2005; 280(49): 40534 - 40543. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, M. Balakrishnan, B. P. Roques, and R. A. Bambara Acceptor RNA Cleavage Profile Supports an Invasion Mechanism for HIV-1 Minus Strand Transfer J. Biol. Chem., April 15, 2005; 280(15): 14443 - 14452. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Gaidamakov, I. I. Gorshkova, P. Schuck, P. J. Steinbach, H. Yamada, R. J. Crouch, and S. M. Cerritelli Eukaryotic RNases H1 act processively by interactions through the duplex RNA-binding domain Nucleic Acids Res., April 14, 2005; 33(7): 2166 - 2175. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Budihas, I. Gorshkova, S. Gaidamakov, A. Wamiru, M. K. Bona, M. A. Parniak, R. J. Crouch, J. B. McMahon, J. A. Beutler, and S. F. J. Le Grice Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones Nucleic Acids Res., March 1, 2005; 33(4): 1249 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Nikolenko, S. Palmer, F. Maldarelli, J. W. Mellors, J. M. Coffin, and V. K. Pathak Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: Balance between RNase H activity and nucleotide excision PNAS, February 8, 2005; 102(6): 2093 - 2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Julias, M. J. McWilliams, S. G. Sarafianos, W. G. Alvord, E. Arnold, and S. H. Hughes Effects of Mutations in the G Tract of the Human Immunodeficiency Virus Type 1 Polypurine Tract on Virus Replication and RNase H Cleavage J. Virol., December 1, 2004; 78(23): 13315 - 13324. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Klumpp, J. Q. Hang, S. Rajendran, Y. Yang, A. Derosier, P. Wong Kai In, H. Overton, K. E. B. Parkes, N. Cammack, and J. A. Martin Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors Nucleic Acids Res., December 1, 2003; 31(23): 6852 - 6859. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. McWilliams, J. G. Julias, S. G. Sarafianos, W. G. Alvord, E. Arnold, and S. H. Hughes Mutations in the 5' End of the Human Immunodeficiency Virus Type 1 Polypurine Tract Affect RNase H Cleavage Specificity and Virus Titer J. Virol., October 15, 2003; 77(20): 11150 - 11157. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Julias, M. J. McWilliams, S. G. Sarafianos, W. G. Alvord, E. Arnold, and S. H. Hughes Mutation of Amino Acids in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase That Contact the Template-Primer Affects RNase H Activity J. Virol., August 1, 2003; 77(15): 8548 - 8554. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lener, S. R. Budihas, and S. F. J. Le Grice Mutating Conserved Residues in the Ribonuclease H Domain of Ty3 Reverse Transcriptase Affects Specialized Cleavage Events J. Biol. Chem., July 12, 2002; 277(29): 26486 - 26495. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Julias, M. J. McWilliams, S. G. Sarafianos, E. Arnold, and S. H. Hughes Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo PNAS, July 9, 2002; 99(14): 9515 - 9520. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Julias, A. L. Ferris, P. L. Boyer, and S. H. Hughes Replication of Phenotypically Mixed Human Immunodeficiency Virus Type 1 Virions Containing Catalytically Active and Catalytically Inactive Reverse Transcriptase J. Virol., July 15, 2001; 75(14): 6537 - 6546. [Abstract] [Full Text] |
||||
![]() |
A. G. Campbell Expression of Moloney Murine Leukemia Virus RNase H Rescues the Growth Defect of an Escherichia coli Mutant J. Virol., July 1, 2001; 75(13): 6212 - 6217. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Dang and W.-S. Hu Effects of Homology Length in the Repeat Region on Minus-Strand DNA Transfer and Retroviral Replication J. Virol., January 15, 2001; 75(2): 809 - 820. [Abstract] [Full Text] |
||||
![]() |
R. H. Archer, C. Dykes, P. Gerondelis, A. Lloyd, P. Fay, R. C. Reichman, R. A. Bambara, and L. M. Demeter Mutants of Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Resistant to Nonnucleoside Reverse Transcriptase Inhibitors Demonstrate Altered Rates of RNase H Cleavage That Correlate with HIV-1 Replication Fitness in Cell Culture J. Virol., September 15, 2000; 74(18): 8390 - 8401. [Abstract] [Full Text] |
||||
![]() |
J. L. Keck, E. R. Goedken, and S. Marqusee Activation/Attenuation Model for RNase H. A ONE-METAL MECHANISM WITH SECOND-METAL INHIBITION J. Biol. Chem., December 18, 1998; 273(51): 34128 - 34133. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Smith, O. Leon, J. S. Smith, and M. J. Roth Sequence Requirements for Removal of tRNA by an Isolated Human Immunodeficiency Virus Type 1 RNase H Domain J. Virol., August 1, 1998; 72(8): 6805 - 6812. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhan and R. J. Crouch The Isolated RNase H Domain of Murine Leukemia Virus Reverse Transcriptase. RETENTION OF ACTIVITY WITH CONCOMITANT LOSS OF SPECIFICITY J. Biol. Chem., August 29, 1997; 272(35): 22023 - 22029. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Rausch and S. F.J. Le Grice Substituting a Conserved Residue of the Ribonuclease H Domain Alters Substrate Hydrolysis by Retroviral Reverse Transcriptase J. Biol. Chem., March 28, 1997; 272(13): 8602 - 8610. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ghosh, K. J. Howard, C. E. Cameron, S. J. Benkovic, S. H. Hughes, and S. F. J. Le Grice Truncating alpha-Helix E` of p66 Human Immunodeficiency Virus Reverse Transcriptase Modulates RNase H Function and Impairs DNA Strand Transfer J. Biol. Chem., March 31, 1995; 270(13): 7068 - 7076. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |